Title : Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib.

Pub. Date : 2012

PMID : 22890083






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To compare the assessment of response and prognosis of patients to sorafenib treatment by the Response Evaluation Criteria in Solid Tumors (RECIST), modified RECIST (mRECIST), alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP). Sorafenib angiotensin I converting enzyme Homo sapiens